Pharma & Biotech

Lyell Immunopharma has initiated its crucial Phase 3 clinical trial, named PiNACLE - H2H, for its next-generation CAR T-cell therapy...

Shares of Plus Therapeutics experienced significant price swings on Thursday, staging a notable recovery from recent weakness despite remaining at...

Shares of clinical-stage biopharmaceutical company Olema Pharmaceuticals experienced a dramatic rally in September, climbing nearly 50% in a single month....

Walgreens Boots Alliance has officially concluded its tenure as a publicly traded company following its full acquisition by private equity...

Shares of Humacyte experienced a dramatic and unexplained surge, climbing more than 20% in a single trading session. This sharp...

A clinical-stage biotechnology company has captured market attention with compelling trial results for its novel therapeutic candidate. Kodiak Sciences Inc....

The 2023 acquisition of biopharmaceutical firm Chinook Therapeutics by Swiss giant Novartis has culminated in a stark narrative of contrast....

Biotechnology firm Ocugen finds itself at a critical juncture, simultaneously managing a significant corporate setback and a promising new international...

Gene therapy specialist Krystal Biotech has achieved a significant regulatory milestone that is driving substantial investor interest. The company's flagship...

Shares of Vera Therapeutics experienced a notable upswing, closing at $26.15 after a robust 7% gain. This market movement was...